Annualized 3Q07 Lovenox sales by region
(as reported by SNY):
US: €1.54B ($2.22B), 61% of total, +15% YoY
EU: €724M ($1.05B), 29% of total, +10% YoY
RoW: €272M ($393M), 11% of total, +10% YoY
===
Total: €2.53B ($3.66B), +13% YoY
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”